Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modelo: cas no 1038915-60-4
Marca: Dm
productividad: 100kg/month
transporte: Ocean,Air
Lugar de origen: Hebei, China
Apoyo sobre: 100kg/month
Certificados : ISO9001
Hafen: Shanghai
Tipo de Pago: L/C,T/T
Incoterm: FOB,CIF
CAS NO 1038915-60-4 NIRAPARIB
Sinónimos:
2- [4- (3S) -3-Piperidinilfenil] -2H-indazol-7-carboxamida; MK-4827
(S) -2- (4- (Piperidin-3-il) fenil) -2H-indazol-7-carboxamida
NIRAPARIB es un inhibidor de parpa de molécula pequeña oralmente activa desarrollada por Tesaro para tratar el cáncer de ovario.
NIRAPARIB se utiliza para el tratamiento de mantenimiento de pacientes adultos con ovárico epitelial recurrente, trompa de Falopio o cáncer peritoneal primario que se encuentran en respuesta total o parcial a la quimioterapia basada en platino.
Test Items |
Specification |
Test Results |
Appearance |
White powder |
White powder |
Melting point |
125~127°C |
Conforms |
Specific Rotation |
+28°~+30° |
+29° |
Acidity(PH) |
5.2~6.5 |
5.8~6.2 |
Water |
4.0%~5.5% |
5.0% |
Residue On Ignition |
Not more than 0.1% |
Conforms |
N.N - dimethylaniline |
Comply with the standard |
Conforms |
Phenolic Compounds |
Comply with the standard |
Conforms |
Related Substance |
Comply with the standard |
Conforms |
Assay |
Between99.0~102.0% |
99.53% |
Conclusion |
This batch is complies with USP 41 |
PRODUCTOS POR GRUPO : API e intermedios > APIS en polvo
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.